Search - tctmd.com

Displaying 81 - 100 of 100

Sort: Relevancy | Date

Presentation TCT 2013

Stable Angina: PCI vs. CABG vs. OMT

Presenter: Thomas Tu

October 27, 2013

News Daily News

冠状动脉多支病变疗法比较发现10年时相似左心室射血分数

L.A. McKeown

July 24, 2013

News Daily News

Una Comparativa de Tratamientos contra EAC Multivaso halla una Preservación LVEF Similar a los 10 Años

L.A. McKeown

July 24, 2013

News Daily News

Comparison of Therapies in Multivessel CAD Finds Similar LVEF Preservation at 10 Years

L.A. McKeown

July 24, 2013

News Daily News

COURAGE: 医药治疗‘跨越’是因出现更多症状而非更多硬事件

July 19, 2013

News Daily News

COURAGE: Medical Therapy ‘Crossovers’ Have More Symptoms, not More Hard Events

July 19, 2013

News Conference News TCT 2012

Paradigm Shift from Ischemia to Vulnerable Plaque Needed to Prevent Sudden Coronary Death

October 24, 2012

News Industry News

FFR-Guided PCI Demonstrates Cost-Effectiveness When Compared to Medical Therapy for Stable Coronary Artery Disease

October 24, 2012

Presentation TCT 2012

Position 1. Use PCI and DES Sparingly, and if at All, Only After OMT Truly Fails!

Presenter: David Brown

October 22, 2012

Presentation TCT 2012

Case Presentation (with Discussion): DES vs. BMS vs. OMT in Stable Ischemic Heart Disease

Presenter: Frederick Feit

October 22, 2012

News Conference News TCT 2012

COURAGE, FAME: Revascularization More Effective Than OMT

October 22, 2012

News Conference News ESC 2012

FAME 2: PCI Bests Medical Therapy in Stable Patients with Proven Ischemia

August 28, 2012

News Conference News EuroPCR 2012

EuroPCR 2012: Biodegradable Devices, Imaging Take Center Stage

Caitlin E. Cox

May 22, 2012

News Conference News EuroPCR 2012

FAME II: FFR Pinpoints Stable CAD Patients Who Need PCI in Addition to Medical Therapy

Caitlin E. Cox

May 15, 2012

News Industry News

FAME II Trial Demonstrates FFR-Guided PCI Superior to Medical Treatment in Preliminary Findings

May 14, 2012

News Industry News

Independent Data Safety Monitoring Board Recommends St. Jude Medical’s FAME II Clinical Trial Stop Enrollment Following Positive Interim Analysis

January 17, 2012

News Industry News

NIH Awards $84 Million Grant to NYU Langone Medical Center and Partnering Institutions for First-of-Its-Kind Comparative Effectiveness ISCHEMIA Clinical Trial

August 01, 2011

News Daily News

Since COURAGE, Little Change in Optimal Medical Therapy for Stable PCI Patients

Caitlin E. Cox

May 10, 2011

News Daily News

COURAGE: PCI Not Cost-Effective Even for Highly Symptomatic Patients

February 15, 2011

CME

Advertisement

Stable Angina: PCI vs. CABG vs. OMT

冠状动脉多支病变疗法比较发现10年时相似左心室射血分数

Una Comparativa de Tratamientos contra EAC Multivaso halla una Preservación LVEF Similar a los 10 Años

Comparison of Therapies in Multivessel CAD Finds Similar LVEF Preservation at 10 Years

COURAGE: 医药治疗‘跨越’是因出现更多症状而非更多硬事件

COURAGE: Medical Therapy ‘Crossovers’ Have More Symptoms, not More Hard Events

Paradigm Shift from Ischemia to Vulnerable Plaque Needed to Prevent Sudden Coronary Death

FFR-Guided PCI Demonstrates Cost-Effectiveness When Compared to Medical Therapy for Stable Coronary Artery Disease

Position 1. Use PCI and DES Sparingly, and if at All, Only After OMT Truly Fails!

Case Presentation (with Discussion): DES vs. BMS vs. OMT in Stable Ischemic Heart Disease

COURAGE, FAME: Revascularization More Effective Than OMT

FAME 2: PCI Bests Medical Therapy in Stable Patients with Proven Ischemia

EuroPCR 2012: Biodegradable Devices, Imaging Take Center Stage

FAME II: FFR Pinpoints Stable CAD Patients Who Need PCI in Addition to Medical Therapy

FAME II Trial Demonstrates FFR-Guided PCI Superior to Medical Treatment in Preliminary Findings

Independent Data Safety Monitoring Board Recommends St. Jude Medical’s FAME II Clinical Trial Stop Enrollment Following Positive Interim Analysis

NIH Awards $84 Million Grant to NYU Langone Medical Center and Partnering Institutions for First-of-Its-Kind Comparative Effectiveness ISCHEMIA Clinical Trial

Since COURAGE, Little Change in Optimal Medical Therapy for Stable PCI Patients

COURAGE: PCI Not Cost-Effective Even for Highly Symptomatic Patients

A New Era of P2Y12 Inhibitors: Transitioning from Intravenous to Oral Platelet Inhibitors after PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content